Intrathecal liposomal cytarabine: More friend than foe?

被引：14

作者：

Bhojwani, Deepa ^{[1
]}

Pui, Ching-Hon

机构：

[1] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA

来源：

LEUKEMIA & LYMPHOMA | 2008年 / 49卷 / 08期

关键词：

D O I：

10.1080/10428190802220527

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1427 / 1430

页数：4

共 14 条

[1] Feasibility and toxicity of intrathecal liposomal cytarabine in 5 children and young adults with refractory neoplastic meningitis [J].

Benesch, Martin ;

Sovinz, Petra ;

Krammer, Barbara ;

Lackner, Herwig ;

Mann, Georg ;

Schwinger, Wolfgang ;

Gadner, Helmut ;

Urban, Christian .

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2007, 29 (04) :222-226

[2] Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis [J].

Bomgaars, L ;

Geyer, JR ;

Franklin, J ;

Dahl, G ;

Park, J ;

Winick, NJ ;

Klenke, R ;

Berg, SL ;

Blaney, SM .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (19) :3916-3921

[3] PHARMACOKINETICS OF INTRALUMBAR DTC-101 FOR THE TREATMENT OF LEPTOMENINGEAL METASTASES [J].

CHAMBERLAIN, MC ;

KORMANIK, P ;

HOWELL, SB ;

KIM, S .

ARCHIVES OF NEUROLOGY, 1995, 52 (09) :912-917

[4] Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis [J].

Glantz, MJ ;

LaFollette, S ;

Jaeckle, KA ;

Shapiro, W ;

Swinnen, L ;

Rozental, JR ;

Phuphanich, S ;

Rogers, LR ;

Gutheil, JC ;

Batchelor, T ;

Lyter, D ;

Chamberlain, M ;

Maria, BL ;

Schiffer, C ;

Bashir, R ;

Thomas, D ;

Cowens, W ;

Howell, SB .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) :3110-3116

[5]

Glantz MJ, 1999, CLIN CANCER RES, V5, P3394

[6] Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia [J].

Jabbour, Elias ;

O'Brien, Susan ;

Kantarjian, Hagop ;

Garcia-Manero, Guillermo ;

Ferrajoli, Alessandra ;

Ravandi, Farhad ;

Cabanillas, Maria ;

Thomas, Deborah A. .

BLOOD, 2007, 109 (08) :3214-3218

[7] Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine [J].

Jaeckle, KA ;

Phuphanich, S ;

van den Bent, MJ ;

Aiken, R ;

Batchelor, T ;

Campbell, T ;

Fulton, D ;

Gilbert, M ;

Heros, D ;

Rogers, L ;

O'Day, SJ ;

Akerley, W ;

Allen, J ;

Baldas, S ;

Gertler, SZ ;

Greenberg, HS ;

LaFollette, S ;

Lesser, G ;

Mason, W ;

Recht, L ;

Wong, E ;

Chamberlain, MC ;

Cohn, A ;

Glantz, MJ ;

Guthell, JC ;

Maria, B ;

Moots, P ;

New, P ;

Russell, C ;

Shapiro, W ;

Swinnen, L ;

Howell, SB .

BRITISH JOURNAL OF CANCER, 2001, 84 (02) :157-163

[8] EXTENDED CSF CYTARABINE EXPOSURE FOLLOWING INTRATHECAL ADMINISTRATION OF DTC-101 [J].

KIM, S ;

CHATELUT, E ;

KIM, JC ;

HOWELL, SB ;

CATES, C ;

KORMANIK, PA ;

CHAMBERLAIN, MC .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (11) :2186-2193

[9] Intrathecal liposomal cytarabine for prevention of meningeal disease in patients with acute lymphocytic leukemia and high-grade lymphoma [J].

McClune, Brian ;

Buadi, Francis K. ;

Aslam, Naveed ;

Przepiorka, Donna .

LEUKEMIA & LYMPHOMA, 2007, 48 (09) :1849-1851

[10] Efficacy and safety of intrathecal liposomal cytarabine for the treatment of meningeal relapse in acute lymphoblastic leukemia: Experience of two pediatric institutions [J].

Parasole, Rosanna ;

Menna, Giuseppe ;

Marra, Nicoletta ;

Petruzziello, Fara ;

Locatelli, Franco ;

Mangione, Argia ;

Misuraca, Aldo ;

Buffardi, Salvatore ;

Di Cesare-Merlone, Alessandra ;

Poggi, Vincenzo .

LEUKEMIA & LYMPHOMA, 2008, 49 (08) :1553-1559

← 1 2 →